Dr Shelley A Morris, DO | |
12340 Bittersweet Commons Blvd W, Granger, IN 46530-6959 | |
(574) 271-8610 | |
(574) 271-8620 |
Full Name | Dr Shelley A Morris |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 17 Years |
Location | 12340 Bittersweet Commons Blvd W, Granger, Indiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376737387 | NPI | - | NPPES |
236040021 | Other | IN | MEDICARE PTAN |
200994220 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 02003725A (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Hospital Of South Bend | South bend, IN | Hospital |
Elkhart General Hospital | Elkhart, IN | Hospital |
Saint Joseph Regional Medical Center | Mishawaka, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Beacon Medical Group Inc | 1254243306 | 452 |
News Archive
While Oregon ranks highly nationwide for its gender-affirming policies and health care for transgender women, many of those polices are not fully realized in practice, a recent study from Oregon State University found.
Mayo Clinic researchers have discovered an association between a commonly prescribed blood pressure drug, Olmesartan, and severe gastrointestinal issues such as nausea, vomiting, diarrhea, weight loss and electrolyte abnormalities - symptoms common among those who have celiac disease. The findings are published online today in the medical journal Mayo Clinic Proceedings.
ARIAD Pharmaceuticals, Inc. today announced the initiation of the Phase 2 trial of Iclusig (ponatinib) in adult patients with metastatic and/or unresectable gastrointestinal stromal tumors.
Researchers from Joslin Diabetes Center, Boston, and ActiveSite Pharmaceuticals, Inc., San Francisco, announced today that they have demonstrated that a specific inhibitor of the protease plasma kallikrein, ASP-440, developed by ActiveSite Pharmaceuticals, may provide a new therapeutic approach for treatment of diabetic retinopathy, the most common eye-related complication of diabetes.
› Verified 3 days ago
Entity Name | Beacon Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033161617 PECOS PAC ID: 1254243306 Enrollment ID: O20031105000657 |
News Archive
While Oregon ranks highly nationwide for its gender-affirming policies and health care for transgender women, many of those polices are not fully realized in practice, a recent study from Oregon State University found.
Mayo Clinic researchers have discovered an association between a commonly prescribed blood pressure drug, Olmesartan, and severe gastrointestinal issues such as nausea, vomiting, diarrhea, weight loss and electrolyte abnormalities - symptoms common among those who have celiac disease. The findings are published online today in the medical journal Mayo Clinic Proceedings.
ARIAD Pharmaceuticals, Inc. today announced the initiation of the Phase 2 trial of Iclusig (ponatinib) in adult patients with metastatic and/or unresectable gastrointestinal stromal tumors.
Researchers from Joslin Diabetes Center, Boston, and ActiveSite Pharmaceuticals, Inc., San Francisco, announced today that they have demonstrated that a specific inhibitor of the protease plasma kallikrein, ASP-440, developed by ActiveSite Pharmaceuticals, may provide a new therapeutic approach for treatment of diabetic retinopathy, the most common eye-related complication of diabetes.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Shelley A Morris, DO 710 N Niles Ave, South Bend, IN 46617-1924 Ph: (574) 647-1610 | Dr Shelley A Morris, DO 12340 Bittersweet Commons Blvd W, Granger, IN 46530-6959 Ph: (574) 271-8610 |
News Archive
While Oregon ranks highly nationwide for its gender-affirming policies and health care for transgender women, many of those polices are not fully realized in practice, a recent study from Oregon State University found.
Mayo Clinic researchers have discovered an association between a commonly prescribed blood pressure drug, Olmesartan, and severe gastrointestinal issues such as nausea, vomiting, diarrhea, weight loss and electrolyte abnormalities - symptoms common among those who have celiac disease. The findings are published online today in the medical journal Mayo Clinic Proceedings.
ARIAD Pharmaceuticals, Inc. today announced the initiation of the Phase 2 trial of Iclusig (ponatinib) in adult patients with metastatic and/or unresectable gastrointestinal stromal tumors.
Researchers from Joslin Diabetes Center, Boston, and ActiveSite Pharmaceuticals, Inc., San Francisco, announced today that they have demonstrated that a specific inhibitor of the protease plasma kallikrein, ASP-440, developed by ActiveSite Pharmaceuticals, may provide a new therapeutic approach for treatment of diabetic retinopathy, the most common eye-related complication of diabetes.
› Verified 3 days ago
Dr. Leah Napolitano, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12563 State Rd 23, Granger, IN 46530 Phone: 574-335-8300 Fax: 574-335-0775 | |
Dr. Christopher J Quinn, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 52500 Fir Rd, Granger, IN 46530 Phone: 574-271-0700 Fax: 574-273-5648 | |
Michael Dennison Conroy, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 16205 Baywood Ln, Granger, IN 46530 Phone: 574-271-0244 | |
Dr. Joseph H Cerbin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 52500 Fir Rd, Granger, IN 46530 Phone: 574-271-0700 Fax: 574-273-5648 | |
Dr. Justin Reed, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 52500 Fir Rd, Granger, IN 46530 Phone: 574-271-0700 | |
Dr. David Charles Grellmann, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6913 N Main St, Granger, IN 46530 Phone: 574-647-1500 Fax: 574-243-4306 | |
Dr. Scott Michael Eshowsky, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6913 N Main St Ste 300, Granger, IN 46530 Phone: 574-647-1500 Fax: 574-647-2567 |